Co-Ligne AG – Trademark Portfolio
Entity Type: 03
Co-Ligne AG holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 17 (Rubber Goods) across 6 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OSTA-PEK and CO-LIGNE, A STRATEGY IN SPINE. The owner is based in 75004 Paris.
Rue de Temple 39
75004 Paris , FR
Showing of trademarks Trademarks
Trademark Classifications
Co-Ligne AG's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Co-Ligne AG have?
Co-Ligne AG has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.
What trademark classes does Co-Ligne AG file in?
Co-Ligne AG files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 17 (Rubber Goods), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Co-Ligne AG's most well-known trademarks?
Co-Ligne AG's registered trademark portfolio includes well-known marks such as OSTA-PEK and CO-LIGNE, A STRATEGY IN SPINE. These are among 2 currently registered trademarks in the portfolio.
What is Co-Ligne AG's trademark registration success rate?
Co-Ligne AG has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.